The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt
- PMID: 25945596
- DOI: 10.1089/mdr.2014.0226
The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt
Abstract
Background: OmpK35 and OmpK36 are the major outer membrane porins of Klebsiella pneumoniae. We aimed to study the effect of combined porin loss and production of extended-spectrum β-lactamases (ESBLs) on imipenem susceptibility among K. pneumoniae clinical isolates.
Materials and methods: This study included 91 suspected ESBL-producing K. pneumoniae clinical isolates, isolated from different patient specimens at the Cairo University hospital from January to June 2010. All isolates were subjected to genotypic analysis of the outer membrane protein gene expression using reverse transcription-PCR (RT-PCR) and analysis of OmpK35/36 of 38 isolates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Results: By RT-PCR, loss of Omp35 was detected in 78 (85.7%) isolates, loss of Omp36 was detected in 64 (70.32%), and loss of both porins was detected in 62 (68.1%). Out of 91 isolates, 45 (49.5%) were resistant to cefoxitin, and 17 (18.7%) were confirmed as derepressed AmpC producers. Omp35 was lost in all FOX-resistant isolates, whereas Omp36 was lost in 42 (93.3%) (p-value 0.002). The mean of ceftazidime inhibition zone diameter was significantly decreased among ESBL-producing isolates with loss of Omp35/36 (p-value 0.041 and 0.006), respectively. The mean of imipenem minimal inhibitory concentration (MIC) was markedly increased to 8.55 μg/ml among AmpC-producing isolates with Omp35/36 loss, while the mean of imipenem MIC among the 66 confirmed ESBL producers was 0.32 μg/ml.
Conclusion: Imipenem MIC was markedly increased among K. pneumoniae isolates showing AmpC production with loss of both porins OmpK35/36. Meanwhile, the association of porin OmpK35/36 loss with ESBL production was not a direct cause of resistance to imipenem.
Similar articles
-
Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae.Int J Antimicrob Agents. 2018 Dec;52(6):898-905. doi: 10.1016/j.ijantimicag.2018.03.020. Epub 2018 Apr 2. Int J Antimicrob Agents. 2018. PMID: 29621592
-
Effect of Porins and blaKPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?Microb Drug Resist. 2018 Sep;24(7):877-881. doi: 10.1089/mdr.2018.0065. Epub 2018 May 21. Microb Drug Resist. 2018. PMID: 29782237
-
Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.Int J Antimicrob Agents. 2007 Feb;29(2):201-6. doi: 10.1016/j.ijantimicag.2006.09.006. Epub 2007 Jan 3. Int J Antimicrob Agents. 2007. PMID: 17204406
-
Extended-spectrum beta-lactamases and the permeability barrier.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:82-9. doi: 10.1111/j.1469-0691.2007.01860.x. Clin Microbiol Infect. 2008. PMID: 18154531 Review.
-
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.Antimicrob Agents Chemother. 2015 Oct;59(10):5873-84. doi: 10.1128/AAC.01019-15. Epub 2015 Jul 13. Antimicrob Agents Chemother. 2015. PMID: 26169401 Free PMC article. Review.
Cited by
-
Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis.Syst Rev. 2022 Nov 15;11(1):240. doi: 10.1186/s13643-022-02110-3. Syst Rev. 2022. PMID: 36380387 Free PMC article.
-
CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance.Pharmaceuticals (Basel). 2023 Jun 23;16(7):920. doi: 10.3390/ph16070920. Pharmaceuticals (Basel). 2023. PMID: 37513832 Free PMC article. Review.
-
Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.Antimicrob Resist Infect Control. 2023 Apr 4;12(1):29. doi: 10.1186/s13756-023-01220-4. Antimicrob Resist Infect Control. 2023. PMID: 37013626 Free PMC article.
-
Klebsiella pneumonia in Sudan: Multidrug Resistance, Polyclonal Dissemination, and Virulence.Antibiotics (Basel). 2023 Jan 21;12(2):233. doi: 10.3390/antibiotics12020233. Antibiotics (Basel). 2023. PMID: 36830144 Free PMC article.
-
Genetic diversity of carbapenem-resistant Klebsiella Pneumoniae causing neonatal sepsis in intensive care unit, Cairo, Egypt.Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):583-591. doi: 10.1007/s10096-019-03761-2. Epub 2019 Nov 26. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31773363